CSL Sees $5 Bln Non-Cash Impairments, Cuts FY26 Outlook; Stock Plunges
11/5 07:25
(RTTNews) - Shares of CSL Limited (CMXHF.PK, CSL.AX, CSLLY) plunged around 18 percent in Australian trading after the biotech firm on Monday announced that it now expects an additional $5 billion impairment charge for fiscal 2026 and 2027, and trimmed outlook for 2026....